Rejuvenating immunity: “anti-aging drug today” eight years later
PDF | HTML | How to cite
Metrics: PDF 2945 views | HTML 5541 views | ?
Mikhail V. Blagosklonny1
1 Cell Stress Biology, Roswell Park Cancer Institute, Buffalo, NY, USA
Mikhail V. Blagosklonny, email:
Keywords: mTOR, TOR, gerosuppression, rapalogs, lifespan, longevity, diseases
Received: February 16, 2015 Accepted: March 28, 2015 Published: March 31, 2015
The 2014 year ended with celebration: Everolimus, a rapamycin analog, was shown to improve immunity in old humans, heralding ‘a turning point’ in research and new era in human quest for immortality. Yet, this turning point was predicted a decade ago. But what will cause human death, when aging will be abolished?
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.